News

Amicus Therapeutics: Opportunity Awaits In This Beaten Down Pharma
Amicus Therapeutics is growing steadily with Galafold and a promising Pompe therapy, targeting $1B revenue by 2028. See why ...
Fabry Disease Market to Grow Rapidly During the Study Period (2020–2034) | DelveInsight
The Fabry disease market is growing due to rising prevalence and better diagnostics. While ERTs and GALAFOLD dominate, emerging gene therapies and new treatments show promise. However, pediatric ...
The Pharma Letter3d
Idorsia names Srishti Gupta as CEO
Swiss pharma company Idorsia (SIX: IDIA) today announced the appointment of Dr Srishti Gupta as chief executive (CEO), ...
Idorsia Pharmaceuticals Ltd: Idorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of Idorsia
Ad hoc announcement pursuant to Art. 53 LR André C. Muller, current CEO of Idorsia, to retire and act as an advisor to the company to ensure a smooth transition Allschwil, Switzerland - June 10 ...
Idorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of Idorsia
Ad hoc announcement pursuant to Art. 53 LR André C. Muller, current CEO of Idorsia, to retire and act as an advisor to the ...